Enron Mail

From:owner-evmba_social@haas.berkeley.edu
To:mba01@haas.berkeley.edu, mba02@haas.berkeley.edu, haasbio@haas.berkeley.edu,ba295c-2@haas.berkeley.edu, mfe02@haas.berkeley.edu, allphds@haas.berkeley.edu, faculty@haas.berkeley.edu, evmba_social@haas.berkeley.edu, ebell@uclink4.berkeley.edu
Subject:Reminder: Martha Amram Real Options talk tomorrow Tuesday
Cc:
Bcc:
Date:Mon, 23 Apr 2001 02:42:00 -0700 (PDT)

Haas Biotech Club, Haas Finance Club and
The Lester Center for Entrepreneurship
are very proud to present


Martha Amram?

"What's Real About Real Options"


Tuesday April 24th 2001
6:30 PM
Wells Fargo Room
Haas School of Business
UC Berkeley


Refreshments will be served
?
------------------------------------------------------------------ About the
talk By Jacob Sagi, Assistant Professor of Finance, Haas School of Business

Martha Amram is one of the leading advocates of the real options approach to
asset valuation. The methodology originated as an economically sound way to
calculate the value of an asset whose management requires sequential
decision-making. For instance, a pharmaceutical company may wish to assess
the value of a speculative research project that, after many stages, may
result in a marketable drug. At each stage the company can decide to proceed
along a number of routes: abandoning the project, moth balling it, or
continuing on a variety of scales. Roughly speaking, the real options
approach selects, from among a universe of possible sequential decision
strategies, a single strategy that maximizes the present value of cash
flows. The cash flows for each strategy are discounted for the risk that the
strategy reflects and not by an ad hoc cost of capital discount factor.

A real options approach to valuation is especially useful when one is trying
to decide whether to defer investment in a project (analogous to deciding
whether an American Call option should be exercised), or when an asset
embodies latent value due to future growth possibilities (e.g., internet
firms). Although academicians have long been proponents of the technique,
there is still a great deal of skepticism among practitioners. This is
largely due to the fact that "optimal" decisions reached via a real options
approach are sensitive to input variables that are not always known reliably
(e.g., the probability that a drug will be deemed successful in human
trials). Regardless, a growing number of firms are opting for the
methodology. This is evidenced by an increase in the number of consulting
firms who employ or specialize in real options analyses.

Tuesday's speaker, Martha Amram, is the author of an important book on the
subject, "Real Options: Managing Strategic Investments in an Uncertain
World," as well as recent articles in the Journal of Business Strategy,
Harvard Business Review and Journal of Applied Corporate Finance. She has
extensive consulting experience and is frequently invited to speak on the
subject of real options. Although some in the business community have
recently branded real options valuations a fad, academicians, like myself,
would contend that the methodology is an important tool that is here to
stay. I therefore encourage all students to come to the talk and learn more
about the advantages and disadvantages of this much-talked-about concept.
?